XML 38 R31.htm IDEA: XBRL DOCUMENT v2.4.0.8
Selected Quarterly Financial Data (Tables)
12 Months Ended
Jun. 30, 2014
Quarterly Financial Information Disclosure [Abstract]  
Schedule of Quarterly Financial Information

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Quarter Ended

 

 

 

 

Fiscal Year 2014

9/30/2013

 

12/31/2013

 

3/31/2014

 

6/30/2014

 

Net sales

$

12,372 

 

$

12,519 

 

$

17,328 

 

$

17,393 

 

Gross profit

 

4,287 

 

 

4,976 

 

 

8,162 

 

 

7,424 

 

Net income (loss)

 

(588)

 

 

(407)

 

 

2,481 

 

 

941 

 

Earnings (loss) per share

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

(0.07)

 

 

(0.05)

 

 

0.27 

 

 

0.10 

 

Diluted

 

(0.07)

 

 

(0.05)

 

 

0.26 

 

 

0.10 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fiscal Year 2013  (1)

9/30/2012

 

12/31/2012

 

3/31/2013

 

6/30/2013

 

Net sales

$

12,148 

 

$

13,229 

 

$

14,765 

 

$

20,744 

 

Gross profit

 

5,597 

 

 

5,199 

 

 

7,345 

 

 

9,979 

 

Income from continuing operations

 

629 

 

 

184 

 

 

1,336 

 

 

3,981 

(2)

Income from discontinued operations

 

26 

 

 

 -

 

 

31 

 

 

23 

 

Net income

 

655 

 

 

184 

 

 

1,367 

 

 

4,004 

 

Earnings per share from continuing operations

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

0.08 

 

 

0.02 

 

 

0.16 

 

 

0.46 

 

Diluted

 

0.08 

 

 

0.02 

 

 

0.16 

 

 

0.46 

 

Earnings per share

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

0.08 

 

 

0.02 

 

 

0.16 

 

 

0.46 

 

Diluted

 

0.08 

 

 

0.02 

 

 

0.16 

 

 

0.46 

 

 

(1)   During the first quarter of fiscal 2013, the Company sold substantially all of the assets of its Commercial Products business unit (see Note 11).  Fiscal 2013 quarters reflect the operations of the Commercial Products business unit as discontinued. 

(2)   In the fourth quarter of fiscal 2013, a long-term investment in preferred stock was redeemed at par resulting in a $1.1 million gain when a previous impairment charge was reversed (see Note 1)